Practical guidance for the evaluation and management of drug hypersensitivity: specific drugs

AD Broyles, A Banerji, S Barmettler, CM Biggs… - The Journal of Allergy …, 2020 - Elsevier
Allergists and clinical immunologists around the world are increasingly faced with the task of
addressing drug allergy and hypersensitivity due to the increase in drug reactions …

Heparin-induced thrombocytopenia (HIT): Review of incidence, diagnosis, and management

M Hogan, JS Berger - Vascular Medicine, 2020 - journals.sagepub.com
Heparin-induced thrombocytopenia (HIT) is a life and limb-threatening complication of
heparin exposure. Here, we review the pathogenesis, incidence, diagnosis, and …

Guidelines on the Use of therapeutic apheresis in clinical practice–Evidence‐Based approach from the Writing Committee of the American Society for Apheresis: The …

L Connelly‐Smith, CR Alquist, NA Aqui… - Journal of clinical …, 2023 - Wiley Online Library
Abstract The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …

Guidelines on the use of therapeutic apheresis in clinical practice–evidence‐based approach from the Writing Committee of the American Society for Apheresis: the …

A Padmanabhan, L Connelly‐Smith… - Journal of clinical …, 2019 - Wiley Online Library
ABSTRACT The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating and categorizing …

How to optimize activated partial thromboplastin time (APTT) testing: solutions to establishing and verifying normal reference intervals and assessing APTT reagents …

EJ Favaloro, G Kershaw… - … in thrombosis and …, 2019 - thieme-connect.com
The activated partial thromboplastin time (APTT) assay is a very common coagulation test,
used for several reasons. The test is conventionally used for assessing the contact factor …

[HTML][HTML] Review and evolution of guidelines for diagnosis of COVID-19 vaccine induced thrombotic thrombocytopenia (VITT)

EJ Favaloro, L Pasalic, G Lippi - Clinical Chemistry and Laboratory …, 2022 - degruyter.com
Abstract Coronavirus disease 2019 (COVID-19) is a life-threatening infectious disease
caused by Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2). In response to …

Drug-induced thrombocytopenia: mechanisms and laboratory diagnostics

E Danese, M Montagnana… - … in thrombosis and …, 2020 - thieme-connect.com
Thrombocytopenia is a condition characterized by a decreased number of platelets in
peripheral blood, which can be caused by a myriad of both congenital and acquired …

Antibodies against platelet factor 4 and their associated pathologies: from HIT/HITT to spontaneous HIT-like syndrome, to COVID-19, to VITT/TTS

EJ Favaloro, L Pasalic, G Lippi - Antibodies, 2022 - mdpi.com
Antibodies against platelet factor 4 (PF4), a protein released from alpha-granules of
activated platelets, may cause a number of pathophysiological conditions. The most …

The complicated relationships of heparin‐induced thrombocytopenia and platelet factor 4 antibodies with COVID‐19

EJ Favaloro, BM Henry, G Lippi - International journal of …, 2021 - Wiley Online Library
Abstract COVID‐19 (coronavirus disease 2019) represents a prothrombotic disorder, and
there have been several reports of platelet factor 4/heparin antibodies being present in …

HIT or miss? A comprehensive contemporary investigation of laboratory tests for heparin induced thrombocytopenia

EJ Favaloro, G McCaughan, S Mohammed, KKE Lau… - Pathology, 2018 - Elsevier
Heparin induced thrombocytopenia (HIT) is a rare but potentially fatal complication of
heparin therapy, which in a proportion of patients causes platelet activation and thrombosis …